Servicewomen and Veterans Menopause Research Act

The Secretary of Defense, in coordination with Secretary of Veterans Affairs, shall evaluate—

(1) the results of research, conducted by either such Secretary, related to menopause, perimenopause, or mid-life women’s health that is complete;

(2) the status of such research that is ongoing; and

(3) any gaps in knowledge and research on—

(A) treatments for menopause-related symptoms;

(B) the safety and effectiveness of treatments for menopause-related symptoms;

(C) the relation to and impact of military service to perimenopause and menopause;

(D) the effect of combat roles on perimenopause and menopause-related symptoms, including exposure to burn pits, toxic chemicals, and perfluoroalkyl and polyfluoroalkyl substances (commonly known as PFAS); and

(E) the impact perimenopause and menopause has on the mental health of women who are members of the Armed Forces or veterans.

Not later than 180 days after the date of the enactment of this Act, each Secretary shall submit to Congress—

(1) a report on the findings of such evaluation; and

(2) a strategic plan that—

(A) resolves the gaps in knowledge and research identified in such report; and

(B) identifies topics in need of further research relating to potential treatments for menopause-related symptoms of women who are members of the Armed Forces or veterans.